Mark Froimson

PCRX

Mark Froimson serves as Director at Pacira BioSciences, Inc. (PCRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$16.2K

Total Sells

2 trades

$112.4K

Net Position

Net Seller

$96.2K

Companies Traded

PCRX

Active Period

Mar 2021 – Aug 2024

3 total trades

Most Recent

Buy PCRX

Aug 12, 2024 · $16.2K

Mark Froimson's Insider Trading at Pacira BioSciences, Inc. (PCRX)

Buys

1 · $16.2K

Sells

2 · $112.4K

Total Shares Bought

1,400

Total Shares Sold

1,734

PCRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 12, 2024↗	Buy	1,400	$11.58	$16.2K	14,473
May 11, 2022↗	Sell	1,000	$59.37	$59.4K	4,908
Mar 17, 2021↗	Sell	734	$72.26	$53.0K	5,242

Related Insiders

WILLIAMS KRISTEN

officer: Chief Administrative Officer

PCRXSell · Feb 2, 2026

WILLIAMS KRISTEN

Chief Administrative Officer

PCRXSell · Feb 2, 2026

RIKER LAUREN

officer: Senior Vice President, Finance

PCRXSell · Feb 2, 2026

Brendan Teehan

Chief Commercial Officer

PCRXSell · Jan 30, 2026

RIKER LAUREN

Senior Vice President, Finance

PCRXSell · Jan 5, 2026

Frank D. Lee

Chief Executive Officer

PCRXSell · Jan 2, 2026

Shawn Cross

Chief Financial Officer

PCRXSell · Dec 10, 2025

BIGAL MARCELO

Director

PCRXSell · Aug 7, 2025

Explore More Insider Trading Data

PCRX Insider Trading Activity

View all insider trades at Pacira BioSciences, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity